軟骨糖蛋白39(CHI3L1)多克隆抗體
Polyclonal Antibody to Chitinase-3-like Protein 1 (CHI3L1)
GP39; CHI3-L1; YKL40; Chondrex; Chitinase 3-Like 1; Chondrocyte Protein YKL40; 39 kDa synovial protein
- 編號PAB463Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB463Mu01-軟骨糖蛋白39(CHI3L1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Mouse Liver Tissue; Primary Ab: 20μg/ml Rabbit Anti-Mouse GP39 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant GP39, Mouse.
-
Figure. Western Blot;1: Mouse Liver Tissue; 2: Mouse Lung Tissue;3:Mouse Spleen Tissue.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對CHI3L1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CHI3L1。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB463Mu01 | 軟骨糖蛋白39(CHI3L1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB463Mu01 | 軟骨糖蛋白39(CHI3L1)多克隆抗體 | WB; IHC; ICC; IP. |
| SEB463Mu | 軟骨糖蛋白39(CHI3L1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| MEB463Mu | 軟骨糖蛋白39(CHI3L1)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB463Mu | 軟骨糖蛋白39(CHI3L1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Molecular and Cellular Biochemistry | Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis? [Pubmed:25421412] |
| BMC Pulmonary Medicine | YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment [Pubmed:25578181] |
| International Journal of Rheumatic Diseases | Assessment of pulsed electromagnetic field therapy with Serum YKL‐40 and ultrasonography in patients with knee osteoarthritis [PubMed: 25955771] |
| Respiratory Research | YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling [Pubmed:27013031] |
| United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html] |
| Chronic obstructive pulmonary disease (COPD)--from biomarkers to clinical phenotypes [ISBN:978-951-51-4039-5] | |
| EYE | YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome [Pubmed: 30560917] |
| European Review for Medical and Pharmacological Sciences | Astrocytes induce proliferation of oligodendrocyte progenitor cells via connexin 47-mediated activation of Chi3l1 expression [Pubmed: 31002152] |
| International journal of molecular sciences | Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients [Pubmed: 31717649] |
| Research square | Oligodendrocyte Progenitor Cells Increase Chi3l1 Secretion in Exosome to Activate Myh9 and Promote Proliferation through Connexin47 Connected to?… [] |
| International Journal of Chronic Obstructive Pulmonary Disease | High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease [33814903] |
留言咨詢
